As the COVID-19 pandemic spreads across the globe, CATO SMS continues to take steps to address the challenges in study conduct that may arise due to illness, quarantine and restricted travel of study participants, clinical investigators, clinical site staff, and monitoring personnel. The events are unprecedented.
Our number one priority is the safety and well-being of trial participants, employees, and sponsors, and we recognize our responsibility to the communities in which we live and work.
Read our operations update here.
Let us partner with your team on bringing new therapies to light. Get in touch to get started.